Theravance Biopharma R&D Ip, Llc V. Eugia Pharma Specialties Ltd. - 1:23-cv-00926

Theravance Biopharma R&D Ip, Llc V. Eugia Pharma Specialties Ltd. (Case No. 1:23-cv-00926), filed on Feb 16, 2023 in the District Court, D. New Jersey involving patent infringement. This case involves patent infringement claims between the parties. Explore details about the litigants, key filings, and major docket updates.

Case Details

Case Number
1:23-cv-00926
Filing Date
Feb 16, 2023
Cause of Action
Patent Infringement
Status
-
Court
District Court, D. New Jersey
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
MEDICHEM USA, LLC -
LUPIN LTD. -
LIFESTAR PHARMA LLC -
MYLAN IRELAND LIMITED -
INTAS PHARMACEUTICALS LTD. -
THERAVANCE BIOPHARMA IRELAND LIMITED -
CIPLA LIMITED -
MANKIND PHARMA LTD. -
ACCORD HEALTHCARE INC. -
TEVA PHARMACEUTICAL INDUSTRIES LTD. -
AUROBINDO PHARMA USA, INC. -
EUGIA PHARMA SPECIALITIES LTD. -
ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMITED -

Patents Involved

Patents not found - set an alert to get notified when patents are added.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Aug 6, 2025OPINION. Signed by Judge Karen M. Williams on 8/6/25. (nar)PACER Document